Bevacizumab combined with weekly paclitaxel, pegylated liposomal doxorubicin, or topotecan in platinum-resistant recurrent ovarian cancer: Analysis by chemotherapy cohort of the randomized phase III aurelia trial

Andres M. Poveda, Frédéric Selle, Felix Hilpert, Alexander Reuss, Antonella Savarese, Ignace Vergote, Petronella Witteveen, Aristotelis Bamias, Nana Scotto, Lada Mitchell, Eric Pujade-Lauraine

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)3836-3838
Number of pages3
JournalJournal of Clinical Oncology
Issue number32
Publication statusPublished - Nov 10 2015

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this